METHODIST DALLAS MEDICAL CENTER — History
CCN 450051 | 3-year financial timeline | COVID resilience: 59/100
🛡️ Public data only — no PHI permitted on this instance.
$556M
Latest Revenue (FY2022)
+6.6%
Revenue CAGR (3yr)
-5.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $489M | $522M | $556M | +6.5% | +6.6% |
| Operating Expenses | $519M | $549M | $586M | +6.7% | +6.2% |
| Operating Margin | -6.2% | -5.2% | -5.4% | -2.8% | +0.0% |
| Net Income | $-30M | $-27M | $-30M | -9.5% | +0.0% |
| Licensed Beds | 378 | 367 | 375 | +2.2% | -0.4% |
| Total Patient Days | 85,512 | 87,181 | 91,098 | +4.5% | +3.2% |
| Medicare Day % | 19% | 17% | 14% | -17.5% | -13.8% |
| Medicaid Day % | 5% | 5% | 4% | -21.1% | -11.5% |
COVID Impact & Recovery
Resilience Score: 59/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +13.6% ($489M → $556M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+6.6%
This Hospital
+7.6%
State Avg
Latest Margin
-5.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $589M | -5.0% |
| FY2024 (proj) | $622M | -4.6% |
| FY2025 (proj) | $656M | -4.2% |